InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-13.1%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Tammara Vijay, VP Senior. Officer active across 1 company, notably Ocugen, Inc.. Aggregated, 4 disclosures have been recorded. Activity tracked since 29 April 2021. The latest transaction was disclosed on 4 May 2021 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Declarations4 total
4,900 sharesCommon StockSEC:0001192482-21-000405
4,900 shares@ US$0.460.0004% mcap21.6% of flowCommon StockSEC:0001192482-21-000405:0
9,000 shares@ US$0.4639.2% of flowComm StockSEC:0001192482-21-000388
9,000 shares@ US$0.460.0008% mcap39.2% of flowComm StockSEC:0001192482-21-000388:0
4 of 4 declarations
About Tammara Vijay
Vijay Tammara is the Senior Vice President at Ocugen, Inc. and also serves as the Chief Executive Officer. He oversees the operations of the company, which focuses on developing innovative therapies for eye diseases. Tammara is responsible for strategy and innovation, aiming to improve patient outcomes.
